NL298071A - - Google Patents

Info

Publication number: NL298071A
Authority: NL; Netherlands

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1963-06-04

Publication of NL298071A publication Critical patent/NL298071A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

NL298071D 1963-06-04 NL298071A (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US285500A US3296249A (en)	1963-06-04	1963-06-04	5-monocyclic aryl-1, 3-dihydro-2h-1, 4-benzodiazepin-2-ones

Publications (1)

Publication Number	Publication Date
NL298071A true NL298071A (zh)

Family

ID=23094505

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL298071D NL298071A (zh)	1963-06-04

Country Status (7)

Country	Link
US (1)	US3296249A (zh)
DE (1)	DE1445424A1 (zh)
DK (1)	DK107811C (zh)
ES (1)	ES291045A2 (zh)
FI (1)	FI46847C (zh)
NL (1)	NL298071A (zh)
SE (1)	SE310884B (zh)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3401159A (en) *	1966-02-14	1968-09-10	American Home Prod	Benzodiazepine derivatives
US3549623A (en) *	1968-11-14	1970-12-22	Warner Lambert Pharmaceutical	7-r1-1-(r2)-3-hydroxy-5-phenyl-1h-1,4-benzodiazepin-2(3h)-one
US3867529A (en) *	1970-08-24	1975-02-18	Giorgio Ferrari	Tranquilizing and anti-anxiety pharmaceutical compositions
US3886276A (en) *	1971-03-30	1975-05-27	American Home Prod	1,3-Dihydro-3 -hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts in compositions and methods for inducing a calming effect
US4065451A (en) *	1971-03-30	1977-12-27	American Home Products	1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts
BE788899A (fr) *	1971-09-15	1973-01-02	Crc Ricerca Chim	Procede de preparation de derives de benzodiazepine-1,4 one-2 utiles notamment comme agents tranquillisants et sedatifs
USRE31071E (en) *	1971-12-09	1982-11-02	Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler	6-Aza-3H-1,4-benzodiazepines
US4008223A (en) *	1971-12-09	1977-02-15	Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler	6-Aza-3H-1,4-benzodiazepines
US4017616A (en) *	1972-01-21	1977-04-12	American Home Products Corporation	Parenteral benzodiazepine compositions
ES405260A1 (es) *	1972-07-28	1975-07-01	Stabilimenti Chim Farmac Riuni	Procedimiento para la preparacion de 3-hidroxi-5-aril-7- sustituidos-1, 3-dihidro-2h-1, 4-benzodiacepin-2-onas.
US3926952A (en) *	1972-10-03	1975-12-16	American Home Prod	1,4-Benzodiazepin-2-ones and their synthesis
US3860581A (en) *	1972-12-27	1975-01-14	American Home Prod	Preparation of 1,4-benzodiazepines
US4232016A (en) *	1974-12-20	1980-11-04	Merck Patent Gesellschaft Mit Beschraenkter Haftung	3-Fluorobenzodiazepines
US4246270A (en) *	1976-05-26	1981-01-20	E. I. Du Pont De Nemours And Company	3-Fluorobenzodiazepines and compositions and uses thereof
AT361492B (de) *	1978-12-18	1981-03-10	Gerot Pharmazeutika	Verfahren zur herstellung von neuen 3-hydroxy- 1,4-benzodiazepin-2-onen
EP0026848B1 (de) *	1979-09-14	1983-05-04	Sandoz Ag	Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
GR76455B (zh) *	1981-06-04	1984-08-10	Lepetit Spa
US4412952A (en) *	1982-04-30	1983-11-01	Sandoz, Inc.	Process for 3-hydroxy benzodiazepinones
US5382596A (en) *	1993-08-05	1995-01-17	Whitby Research, Inc.	Substituted 2-aminotetralins
EP1265875A4 (en) *	2000-03-06	2003-07-09	Teva Pharma	PROCESS FOR THE PREPARATION OF PURE CRYSTALLINE LORAZEPAM
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US20030051728A1 (en) *	2001-06-05	2003-03-20	Lloyd Peter M.	Method and device for delivering a physiologically active compound
US7645442B2 (en)	2001-05-24	2010-01-12	Alexza Pharmaceuticals, Inc.	Rapid-heating drug delivery article and method of use
US7090830B2 (en) *	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US20070122353A1 (en) *	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US20040105818A1 (en) *	2002-11-26	2004-06-03	Alexza Molecular Delivery Corporation	Diuretic aerosols and methods of making and using them
US7913688B2 (en) *	2002-11-27	2011-03-29	Alexza Pharmaceuticals, Inc.	Inhalation device for producing a drug aerosol
WO2004104490A1 (en)	2003-05-21	2004-12-02	Alexza Pharmaceuticals, Inc.	Self-contained heating unit and drug-supply unit employing same
CA2548917C (en)	2003-12-11	2014-09-23	Sepracor Inc.	Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US7540286B2 (en) *	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US7581540B2 (en) *	2004-08-12	2009-09-01	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
US20100006092A1 (en) *	2004-08-12	2010-01-14	Alexza Pharmaceuticals, Inc.	Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
EP2258357A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis with acetylcholinesterase inhibitor
AU2006304787A1 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) *	2005-10-31	2007-05-17	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
AU2007223036A1 (en) *	2006-03-08	2007-09-13	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) *	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
JP2009536667A (ja)	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	５ｈｔ受容体介在性の神経新生
US20100009983A1 (en) *	2006-05-09	2010-01-14	Braincells, Inc.	5 ht receptor mediated neurogenesis
EP2021000A2 (en)	2006-05-09	2009-02-11	Braincells, Inc.	Neurogenesis by modulating angiotensin
US7998971B2 (en) *	2006-09-08	2011-08-16	Braincells Inc.	Combinations containing a 4-acylaminopyridine derivative
US20080103165A1 (en) *	2006-09-19	2008-05-01	Braincells, Inc.	Ppar mediated modulation of neurogenesis
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
US8530463B2 (en) *	2007-05-07	2013-09-10	Hale Biopharma Ventures Llc	Multimodal particulate formulations
CA2756690C (en)	2008-03-28	2016-08-16	Hale Biopharma Ventures, Llc	Administration of benzodiazepine compositions
US10289671B2 (en) *	2008-05-07	2019-05-14	Microsoft Technology Licensing, Llc	Graphically displaying selected data sources within a grid
WO2010046929A2 (en) *	2008-10-17	2010-04-29	Matrix Laboratories Limited	Novel polymorphic forms of temazepam and processes for preparing the same
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
WO2012174158A2 (en)	2011-06-14	2012-12-20	Hale Biopharma Ventures, Llc	Administration of benzodiazepine
KR20150127037A (ko)	2013-01-09	2015-11-16	엣지몬트 파마슈티칼스 엘엘씨	로라제팜의 제어 방출성 제제
US8999393B1 (en)	2013-01-09	2015-04-07	Edgemont Pharmaceuticals Llc	Sustained release formulations of lorazepam
CN105601576A (zh) *	2016-03-18	2016-05-25	山东新华制药股份有限公司	氯甲西泮的晶型及其制备方法
CN110776473B (zh) *	2019-11-19	2023-09-15	湖南洞庭药业股份有限公司	制备劳拉西泮的方法

0
- NL NL298071D patent/NL298071A/xx unknown
1963
- 1963-06-04 US US285500A patent/US3296249A/en not_active Expired - Lifetime
- 1963-06-19 DK DK278464AA patent/DK107811C/da active
- 1963-08-24 ES ES0291045A patent/ES291045A2/es not_active Expired
- 1963-08-30 DE DE19631445424 patent/DE1445424A1/de active Pending
- 1963-09-10 FI FI631734A patent/FI46847C/fi active
- 1963-09-20 SE SE10290/63A patent/SE310884B/xx unknown

Also Published As

Publication number	Publication date
FI46847B (zh)	1973-04-02
SE310884B (zh)	1969-05-19
ES291045A2 (es)	1963-12-16
FI46847C (fi)	1973-07-10
DK107811C (da)	1967-07-10
DE1445424A1 (de)	1969-02-20
US3296249A (en)	1967-01-03

Publication	Publication Date	Title
AR142945A1 (zh)	1965-02-11
BE627012A (zh)
BE623117A (zh)
BE608372A (zh)
SE310884B (zh)	1969-05-19
BE645781A (zh)	1964-07-16
BE645492A (zh)	1964-07-16
BE645068A (zh)	1964-09-14
BE644598A (zh)	1964-07-01
BE643904A (zh)	1964-06-15
BE643773A (zh)	1964-05-29
BE643478A (zh)	1964-05-29
BE643329A (zh)	1964-05-29
BE643062A (zh)	1964-07-28
BE642626A (zh)
BE642383A (zh)
BE642293A (zh)	1964-07-09
BE642179A (zh)	1964-05-04
BE642096A (zh)	1964-07-03
BE640333A (zh)
BE622160A (zh)
BE627172A (zh)
BE627151A (zh)
BE627145A (zh)
BE627141A (zh)